- Study guides, Class notes & Summaries

Looking for the best study guides, study notes and summaries about ? On this page you'll find 1 study documents about .

All 1 results

Sort by:

Exam (elaborations)

Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers
-

-

-

13

August 2024

2024/2025

A+
Anaemia is present in 35–54% of patients with MF at diagnosis and is considered an unfavourable prognostic factor [3]. With the course of the disease, the rate of anaemia rises and after a year is present in 47–64% of patients [3–6]. Ruxolitinib’s mode of action, as well as the pathophysiological mechanism present in MF, result 170 OncOlOgy in clinical practice 2019, Vol. 15, No. 3 in anaemia (with Hb concentration lower than 10 g/dl), being one of the most common adverse...
TIFFACADEMICS
$16.99 More Info